Baidu
map
J CLIN ENDOCR METAB 润色咨询

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

出版年份：1952 年文章数：15441 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：4.0% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2210203, encodeId=3aa2221020358, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：心血管<br>经验分享：心血管方向，3月26日投稿，三天后技术审查要求提供英文伦理，修改后继续投稿，4月24日返修回来，两个审稿人，总共10条意见，总体很友好，算小修，要求6月22日之前返修回去，5月22日返修回去，经历了under review,6月9日正式接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59c75169226, createdName=146d2680m73(暂无昵称), createdTime=Sun Jun 16 20:32:46 CST 2024, time=2024-06-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2210204, encodeId=48be2210204ba, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：心血管<br>经验分享：心血管方向，3月26日投稿，三天后技术审查要求提供英文伦理，修改后继续投稿，4月24日返修回来，两个审稿人，总共10条意见，总体很友好，算小修，要求6月22日之前返修回去，5月22日返修回去，经历了under review,6月9日正式接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59c75169226, createdName=146d2680m73(暂无昵称), createdTime=Sun Jun 16 20:33:47 CST 2024, time=2024-06-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2200334, encodeId=be5122003344b, content=3-30投稿，4-5under review，4-24 with editor，希望有revise, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7bfb2469150, createdName=jolin_story_47656629, createdTime=Thu Apr 25 12:38:44 CST 2024, time=2024-04-25, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2165427, encodeId=86f3216542ea7, content=为什么回顾性研究也邮件让我发provide the Institutional Review Board or ethical review board’s approval/exemption letter，我明明文章中已经提到which waived the requirement for informed consent because of the retrospective nature of this study啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e43b5476402, createdName=ms4000001768031770, createdTime=Sat Oct 28 16:07:09 CST 2023, time=2023-10-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2212175, encodeId=035c22121e55f, content=审稿速度:1.0<br>偏重的研究方向：内分泌<br>经验分享：请问大家公共数据库是要自己上传还是等编辑通知啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87718511581, createdName=ms7000001498738258, createdTime=Fri Jun 28 21:31:36 CST 2024, time=2024-06-28, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=525028, encodeId=229f52502825, content=原来是Reject<span class="quote">Cactus2013 2016-07-19 发表::<br>研究方向：内分泌;; 06/26/2016 投稿 07/02/2016 Under Review 07/18/2016 Under Review 昨天又更新了一下under review 的日期，不知是几个意思？ </span>, beContent=Cactus2013 2016-07-19 发表:: 研究方向：内分泌;; 06/26/2016 投稿 07/02/2016 Under Review 07/18/2016 Under Review 昨天又更新了一下under review 的日期，不知是几个意思？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=368, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b63d81413, createdName=Cactus2018, createdTime=Thu Jul 21 08:27:00 CST 2016, time=2016-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944787, encodeId=ab53944e87d6, content=2020.09.22投稿，一审3个月，催稿问了下，说是前两个审稿人意见有分歧，所以邀请了第三个审稿人；返回大修2个月；2021.02.04再投，目前with editor了，希望能接收，祈祷, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=795, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLFHmdHZlP01VibUiaSUygPr1vfgUOicNUzicicuib25U9FM5WbtwPBfX6diaZbduz72Vjf0KFc8TINLKKvA/132, createdBy=d1062255989, createdName=延光星辰, createdTime=Tue Mar 02 14:31:35 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571551, encodeId=a9d65e155113, content=审稿速度:3.0<br>经验分享：于2019年2月26日投稿，一篇meta，然后5月18日直接被拒，三个月啊。编者的建议主要是我纳入的中文文献库（CNKI和万方），他们无法重复。所以纳入中文文献的meta慎投这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/0icicabQPFRfglHZr0mpDfC2oYjwL5n0xDc0wODUNEyWJuia9wXP3TnHwrZMktLMl7OQH7ZoUicGQHiclLb373GdibAg/132, createdBy=b44f2541766, createdName=lucifer11, createdTime=Mon May 27 16:57:00 CST 2019, time=2019-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182073, encodeId=9c2d21820e320, content=审稿速度:1.0<br>偏重的研究方向：代谢内分泌<br>经验分享：1.9号投的稿，已经过去7天了，一直在with editor的状态。想请教各位大佬何时才会under review呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d4b8504046, createdName=ms8000001820221539, createdTime=Tue Jan 16 21:41:20 CST 2024, time=2024-01-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2195585, encodeId=5f702195585d8, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：3月18日 投稿，到现在 一直是 Manuscript Submitted！什么情况，我看着大家的速度都挺快啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7b725453206, createdName=ms8000000183026287, createdTime=Wed Mar 27 06:41:54 CST 2024, time=2024-03-27, status=1, ipAttribution=山东省)]
    2024-06-16 146d2680m73(暂无昵称) 来自上海

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向：心血管
    经验分享：心血管方向，3月26日投稿，三天后技术审查要求提供英文伦理，修改后继续投稿，4月24日返修回来，两个审稿人，总共10条意见，总体很友好，算小修，要求6月22日之前返修回去，5月22日返修回去，经历了under review,6月9日正式接收。

    2

    展开2条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2210203, encodeId=3aa2221020358, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：心血管<br>经验分享：心血管方向，3月26日投稿，三天后技术审查要求提供英文伦理，修改后继续投稿，4月24日返修回来，两个审稿人，总共10条意见，总体很友好，算小修，要求6月22日之前返修回去，5月22日返修回去，经历了under review,6月9日正式接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59c75169226, createdName=146d2680m73(暂无昵称), createdTime=Sun Jun 16 20:32:46 CST 2024, time=2024-06-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2210204, encodeId=48be2210204ba, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：心血管<br>经验分享：心血管方向，3月26日投稿，三天后技术审查要求提供英文伦理，修改后继续投稿，4月24日返修回来，两个审稿人，总共10条意见，总体很友好，算小修，要求6月22日之前返修回去，5月22日返修回去，经历了under review,6月9日正式接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59c75169226, createdName=146d2680m73(暂无昵称), createdTime=Sun Jun 16 20:33:47 CST 2024, time=2024-06-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2200334, encodeId=be5122003344b, content=3-30投稿，4-5under review，4-24 with editor，希望有revise, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7bfb2469150, createdName=jolin_story_47656629, createdTime=Thu Apr 25 12:38:44 CST 2024, time=2024-04-25, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2165427, encodeId=86f3216542ea7, content=为什么回顾性研究也邮件让我发provide the Institutional Review Board or ethical review board’s approval/exemption letter，我明明文章中已经提到which waived the requirement for informed consent because of the retrospective nature of this study啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e43b5476402, createdName=ms4000001768031770, createdTime=Sat Oct 28 16:07:09 CST 2023, time=2023-10-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2212175, encodeId=035c22121e55f, content=审稿速度:1.0<br>偏重的研究方向：内分泌<br>经验分享：请问大家公共数据库是要自己上传还是等编辑通知啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87718511581, createdName=ms7000001498738258, createdTime=Fri Jun 28 21:31:36 CST 2024, time=2024-06-28, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=525028, encodeId=229f52502825, content=原来是Reject<span class="quote">Cactus2013 2016-07-19 发表::<br>研究方向：内分泌;; 06/26/2016 投稿 07/02/2016 Under Review 07/18/2016 Under Review 昨天又更新了一下under review 的日期，不知是几个意思？ </span>, beContent=Cactus2013 2016-07-19 发表:: 研究方向：内分泌;; 06/26/2016 投稿 07/02/2016 Under Review 07/18/2016 Under Review 昨天又更新了一下under review 的日期，不知是几个意思？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=368, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b63d81413, createdName=Cactus2018, createdTime=Thu Jul 21 08:27:00 CST 2016, time=2016-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944787, encodeId=ab53944e87d6, content=2020.09.22投稿，一审3个月，催稿问了下，说是前两个审稿人意见有分歧，所以邀请了第三个审稿人；返回大修2个月；2021.02.04再投，目前with editor了，希望能接收，祈祷, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=795, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLFHmdHZlP01VibUiaSUygPr1vfgUOicNUzicicuib25U9FM5WbtwPBfX6diaZbduz72Vjf0KFc8TINLKKvA/132, createdBy=d1062255989, createdName=延光星辰, createdTime=Tue Mar 02 14:31:35 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571551, encodeId=a9d65e155113, content=审稿速度:3.0<br>经验分享：于2019年2月26日投稿，一篇meta，然后5月18日直接被拒，三个月啊。编者的建议主要是我纳入的中文文献库（CNKI和万方），他们无法重复。所以纳入中文文献的meta慎投这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/0icicabQPFRfglHZr0mpDfC2oYjwL5n0xDc0wODUNEyWJuia9wXP3TnHwrZMktLMl7OQH7ZoUicGQHiclLb373GdibAg/132, createdBy=b44f2541766, createdName=lucifer11, createdTime=Mon May 27 16:57:00 CST 2019, time=2019-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182073, encodeId=9c2d21820e320, content=审稿速度:1.0<br>偏重的研究方向：代谢内分泌<br>经验分享：1.9号投的稿，已经过去7天了，一直在with editor的状态。想请教各位大佬何时才会under review呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d4b8504046, createdName=ms8000001820221539, createdTime=Tue Jan 16 21:41:20 CST 2024, time=2024-01-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2195585, encodeId=5f702195585d8, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：3月18日 投稿，到现在 一直是 Manuscript Submitted！什么情况，我看着大家的速度都挺快啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7b725453206, createdName=ms8000000183026287, createdTime=Wed Mar 27 06:41:54 CST 2024, time=2024-03-27, status=1, ipAttribution=山东省)]
    2024-06-16 146d2680m73(暂无昵称) 来自上海

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向：心血管
    经验分享：心血管方向，3月26日投稿，三天后技术审查要求提供英文伦理，修改后继续投稿，4月24日返修回来，两个审稿人，总共10条意见，总体很友好，算小修，要求6月22日之前返修回去，5月22日返修回去，经历了under review,6月9日正式接收。

    2

    展开2条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2210203, encodeId=3aa2221020358, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：心血管<br>经验分享：心血管方向，3月26日投稿，三天后技术审查要求提供英文伦理，修改后继续投稿，4月24日返修回来，两个审稿人，总共10条意见，总体很友好，算小修，要求6月22日之前返修回去，5月22日返修回去，经历了under review,6月9日正式接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59c75169226, createdName=146d2680m73(暂无昵称), createdTime=Sun Jun 16 20:32:46 CST 2024, time=2024-06-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2210204, encodeId=48be2210204ba, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：心血管<br>经验分享：心血管方向，3月26日投稿，三天后技术审查要求提供英文伦理，修改后继续投稿，4月24日返修回来，两个审稿人，总共10条意见，总体很友好，算小修，要求6月22日之前返修回去，5月22日返修回去，经历了under review,6月9日正式接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59c75169226, createdName=146d2680m73(暂无昵称), createdTime=Sun Jun 16 20:33:47 CST 2024, time=2024-06-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2200334, encodeId=be5122003344b, content=3-30投稿，4-5under review，4-24 with editor，希望有revise, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7bfb2469150, createdName=jolin_story_47656629, createdTime=Thu Apr 25 12:38:44 CST 2024, time=2024-04-25, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2165427, encodeId=86f3216542ea7, content=为什么回顾性研究也邮件让我发provide the Institutional Review Board or ethical review board’s approval/exemption letter，我明明文章中已经提到which waived the requirement for informed consent because of the retrospective nature of this study啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e43b5476402, createdName=ms4000001768031770, createdTime=Sat Oct 28 16:07:09 CST 2023, time=2023-10-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2212175, encodeId=035c22121e55f, content=审稿速度:1.0<br>偏重的研究方向：内分泌<br>经验分享：请问大家公共数据库是要自己上传还是等编辑通知啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87718511581, createdName=ms7000001498738258, createdTime=Fri Jun 28 21:31:36 CST 2024, time=2024-06-28, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=525028, encodeId=229f52502825, content=原来是Reject<span class="quote">Cactus2013 2016-07-19 发表::<br>研究方向：内分泌;; 06/26/2016 投稿 07/02/2016 Under Review 07/18/2016 Under Review 昨天又更新了一下under review 的日期，不知是几个意思？ </span>, beContent=Cactus2013 2016-07-19 发表:: 研究方向：内分泌;; 06/26/2016 投稿 07/02/2016 Under Review 07/18/2016 Under Review 昨天又更新了一下under review 的日期，不知是几个意思？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=368, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b63d81413, createdName=Cactus2018, createdTime=Thu Jul 21 08:27:00 CST 2016, time=2016-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944787, encodeId=ab53944e87d6, content=2020.09.22投稿，一审3个月，催稿问了下，说是前两个审稿人意见有分歧，所以邀请了第三个审稿人；返回大修2个月；2021.02.04再投，目前with editor了，希望能接收，祈祷, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=795, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLFHmdHZlP01VibUiaSUygPr1vfgUOicNUzicicuib25U9FM5WbtwPBfX6diaZbduz72Vjf0KFc8TINLKKvA/132, createdBy=d1062255989, createdName=延光星辰, createdTime=Tue Mar 02 14:31:35 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571551, encodeId=a9d65e155113, content=审稿速度:3.0<br>经验分享：于2019年2月26日投稿，一篇meta，然后5月18日直接被拒，三个月啊。编者的建议主要是我纳入的中文文献库（CNKI和万方），他们无法重复。所以纳入中文文献的meta慎投这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/0icicabQPFRfglHZr0mpDfC2oYjwL5n0xDc0wODUNEyWJuia9wXP3TnHwrZMktLMl7OQH7ZoUicGQHiclLb373GdibAg/132, createdBy=b44f2541766, createdName=lucifer11, createdTime=Mon May 27 16:57:00 CST 2019, time=2019-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182073, encodeId=9c2d21820e320, content=审稿速度:1.0<br>偏重的研究方向：代谢内分泌<br>经验分享：1.9号投的稿，已经过去7天了，一直在with editor的状态。想请教各位大佬何时才会under review呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d4b8504046, createdName=ms8000001820221539, createdTime=Tue Jan 16 21:41:20 CST 2024, time=2024-01-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2195585, encodeId=5f702195585d8, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：3月18日 投稿，到现在 一直是 Manuscript Submitted！什么情况，我看着大家的速度都挺快啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7b725453206, createdName=ms8000000183026287, createdTime=Wed Mar 27 06:41:54 CST 2024, time=2024-03-27, status=1, ipAttribution=山东省)]
    2024-04-25 jolin_story_47656629 来自云南省

    3-30投稿，4-5under review，4-24 with editor，希望有revise

    10

    展开10条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2210203, encodeId=3aa2221020358, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：心血管<br>经验分享：心血管方向，3月26日投稿，三天后技术审查要求提供英文伦理，修改后继续投稿，4月24日返修回来，两个审稿人，总共10条意见，总体很友好，算小修，要求6月22日之前返修回去，5月22日返修回去，经历了under review,6月9日正式接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59c75169226, createdName=146d2680m73(暂无昵称), createdTime=Sun Jun 16 20:32:46 CST 2024, time=2024-06-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2210204, encodeId=48be2210204ba, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：心血管<br>经验分享：心血管方向，3月26日投稿，三天后技术审查要求提供英文伦理，修改后继续投稿，4月24日返修回来，两个审稿人，总共10条意见，总体很友好，算小修，要求6月22日之前返修回去，5月22日返修回去，经历了under review,6月9日正式接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59c75169226, createdName=146d2680m73(暂无昵称), createdTime=Sun Jun 16 20:33:47 CST 2024, time=2024-06-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2200334, encodeId=be5122003344b, content=3-30投稿，4-5under review，4-24 with editor，希望有revise, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7bfb2469150, createdName=jolin_story_47656629, createdTime=Thu Apr 25 12:38:44 CST 2024, time=2024-04-25, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2165427, encodeId=86f3216542ea7, content=为什么回顾性研究也邮件让我发provide the Institutional Review Board or ethical review board’s approval/exemption letter，我明明文章中已经提到which waived the requirement for informed consent because of the retrospective nature of this study啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e43b5476402, createdName=ms4000001768031770, createdTime=Sat Oct 28 16:07:09 CST 2023, time=2023-10-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2212175, encodeId=035c22121e55f, content=审稿速度:1.0<br>偏重的研究方向：内分泌<br>经验分享：请问大家公共数据库是要自己上传还是等编辑通知啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87718511581, createdName=ms7000001498738258, createdTime=Fri Jun 28 21:31:36 CST 2024, time=2024-06-28, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=525028, encodeId=229f52502825, content=原来是Reject<span class="quote">Cactus2013 2016-07-19 发表::<br>研究方向：内分泌;; 06/26/2016 投稿 07/02/2016 Under Review 07/18/2016 Under Review 昨天又更新了一下under review 的日期，不知是几个意思？ </span>, beContent=Cactus2013 2016-07-19 发表:: 研究方向：内分泌;; 06/26/2016 投稿 07/02/2016 Under Review 07/18/2016 Under Review 昨天又更新了一下under review 的日期，不知是几个意思？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=368, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b63d81413, createdName=Cactus2018, createdTime=Thu Jul 21 08:27:00 CST 2016, time=2016-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944787, encodeId=ab53944e87d6, content=2020.09.22投稿，一审3个月，催稿问了下，说是前两个审稿人意见有分歧，所以邀请了第三个审稿人；返回大修2个月；2021.02.04再投，目前with editor了，希望能接收，祈祷, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=795, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLFHmdHZlP01VibUiaSUygPr1vfgUOicNUzicicuib25U9FM5WbtwPBfX6diaZbduz72Vjf0KFc8TINLKKvA/132, createdBy=d1062255989, createdName=延光星辰, createdTime=Tue Mar 02 14:31:35 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571551, encodeId=a9d65e155113, content=审稿速度:3.0<br>经验分享：于2019年2月26日投稿，一篇meta，然后5月18日直接被拒，三个月啊。编者的建议主要是我纳入的中文文献库（CNKI和万方），他们无法重复。所以纳入中文文献的meta慎投这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/0icicabQPFRfglHZr0mpDfC2oYjwL5n0xDc0wODUNEyWJuia9wXP3TnHwrZMktLMl7OQH7ZoUicGQHiclLb373GdibAg/132, createdBy=b44f2541766, createdName=lucifer11, createdTime=Mon May 27 16:57:00 CST 2019, time=2019-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182073, encodeId=9c2d21820e320, content=审稿速度:1.0<br>偏重的研究方向：代谢内分泌<br>经验分享：1.9号投的稿，已经过去7天了，一直在with editor的状态。想请教各位大佬何时才会under review呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d4b8504046, createdName=ms8000001820221539, createdTime=Tue Jan 16 21:41:20 CST 2024, time=2024-01-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2195585, encodeId=5f702195585d8, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：3月18日 投稿，到现在 一直是 Manuscript Submitted！什么情况，我看着大家的速度都挺快啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7b725453206, createdName=ms8000000183026287, createdTime=Wed Mar 27 06:41:54 CST 2024, time=2024-03-27, status=1, ipAttribution=山东省)]
    2023-10-28 ms4000001768031770 来自广东省

    为什么回顾性研究也邮件让我发provide the Institutional Review Board or ethical review board’s approval/exemption letter，我明明文章中已经提到which waived the requirement for informed consent because of the retrospective nature of this study啊

    4

    展开4条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2210203, encodeId=3aa2221020358, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：心血管<br>经验分享：心血管方向，3月26日投稿，三天后技术审查要求提供英文伦理，修改后继续投稿，4月24日返修回来，两个审稿人，总共10条意见，总体很友好，算小修，要求6月22日之前返修回去，5月22日返修回去，经历了under review,6月9日正式接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59c75169226, createdName=146d2680m73(暂无昵称), createdTime=Sun Jun 16 20:32:46 CST 2024, time=2024-06-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2210204, encodeId=48be2210204ba, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：心血管<br>经验分享：心血管方向，3月26日投稿，三天后技术审查要求提供英文伦理，修改后继续投稿，4月24日返修回来，两个审稿人，总共10条意见，总体很友好，算小修，要求6月22日之前返修回去，5月22日返修回去，经历了under review,6月9日正式接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59c75169226, createdName=146d2680m73(暂无昵称), createdTime=Sun Jun 16 20:33:47 CST 2024, time=2024-06-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2200334, encodeId=be5122003344b, content=3-30投稿，4-5under review，4-24 with editor，希望有revise, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7bfb2469150, createdName=jolin_story_47656629, createdTime=Thu Apr 25 12:38:44 CST 2024, time=2024-04-25, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2165427, encodeId=86f3216542ea7, content=为什么回顾性研究也邮件让我发provide the Institutional Review Board or ethical review board’s approval/exemption letter，我明明文章中已经提到which waived the requirement for informed consent because of the retrospective nature of this study啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e43b5476402, createdName=ms4000001768031770, createdTime=Sat Oct 28 16:07:09 CST 2023, time=2023-10-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2212175, encodeId=035c22121e55f, content=审稿速度:1.0<br>偏重的研究方向：内分泌<br>经验分享：请问大家公共数据库是要自己上传还是等编辑通知啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87718511581, createdName=ms7000001498738258, createdTime=Fri Jun 28 21:31:36 CST 2024, time=2024-06-28, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=525028, encodeId=229f52502825, content=原来是Reject<span class="quote">Cactus2013 2016-07-19 发表::<br>研究方向：内分泌;; 06/26/2016 投稿 07/02/2016 Under Review 07/18/2016 Under Review 昨天又更新了一下under review 的日期，不知是几个意思？ </span>, beContent=Cactus2013 2016-07-19 发表:: 研究方向：内分泌;; 06/26/2016 投稿 07/02/2016 Under Review 07/18/2016 Under Review 昨天又更新了一下under review 的日期，不知是几个意思？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=368, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b63d81413, createdName=Cactus2018, createdTime=Thu Jul 21 08:27:00 CST 2016, time=2016-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944787, encodeId=ab53944e87d6, content=2020.09.22投稿，一审3个月，催稿问了下，说是前两个审稿人意见有分歧，所以邀请了第三个审稿人；返回大修2个月；2021.02.04再投，目前with editor了，希望能接收，祈祷, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=795, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLFHmdHZlP01VibUiaSUygPr1vfgUOicNUzicicuib25U9FM5WbtwPBfX6diaZbduz72Vjf0KFc8TINLKKvA/132, createdBy=d1062255989, createdName=延光星辰, createdTime=Tue Mar 02 14:31:35 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571551, encodeId=a9d65e155113, content=审稿速度:3.0<br>经验分享：于2019年2月26日投稿，一篇meta，然后5月18日直接被拒，三个月啊。编者的建议主要是我纳入的中文文献库（CNKI和万方），他们无法重复。所以纳入中文文献的meta慎投这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/0icicabQPFRfglHZr0mpDfC2oYjwL5n0xDc0wODUNEyWJuia9wXP3TnHwrZMktLMl7OQH7ZoUicGQHiclLb373GdibAg/132, createdBy=b44f2541766, createdName=lucifer11, createdTime=Mon May 27 16:57:00 CST 2019, time=2019-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182073, encodeId=9c2d21820e320, content=审稿速度:1.0<br>偏重的研究方向：代谢内分泌<br>经验分享：1.9号投的稿，已经过去7天了，一直在with editor的状态。想请教各位大佬何时才会under review呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d4b8504046, createdName=ms8000001820221539, createdTime=Tue Jan 16 21:41:20 CST 2024, time=2024-01-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2195585, encodeId=5f702195585d8, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：3月18日 投稿，到现在 一直是 Manuscript Submitted！什么情况，我看着大家的速度都挺快啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7b725453206, createdName=ms8000000183026287, createdTime=Wed Mar 27 06:41:54 CST 2024, time=2024-03-27, status=1, ipAttribution=山东省)]
    2024-06-28 ms7000001498738258 来自新疆

    审稿速度:1.0
    偏重的研究方向：内分泌
    经验分享：请问大家公共数据库是要自己上传还是等编辑通知啊

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2210203, encodeId=3aa2221020358, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：心血管<br>经验分享：心血管方向，3月26日投稿，三天后技术审查要求提供英文伦理，修改后继续投稿，4月24日返修回来，两个审稿人，总共10条意见，总体很友好，算小修，要求6月22日之前返修回去，5月22日返修回去，经历了under review,6月9日正式接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59c75169226, createdName=146d2680m73(暂无昵称), createdTime=Sun Jun 16 20:32:46 CST 2024, time=2024-06-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2210204, encodeId=48be2210204ba, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：心血管<br>经验分享：心血管方向，3月26日投稿，三天后技术审查要求提供英文伦理，修改后继续投稿，4月24日返修回来，两个审稿人，总共10条意见，总体很友好，算小修，要求6月22日之前返修回去，5月22日返修回去，经历了under review,6月9日正式接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59c75169226, createdName=146d2680m73(暂无昵称), createdTime=Sun Jun 16 20:33:47 CST 2024, time=2024-06-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2200334, encodeId=be5122003344b, content=3-30投稿，4-5under review，4-24 with editor，希望有revise, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7bfb2469150, createdName=jolin_story_47656629, createdTime=Thu Apr 25 12:38:44 CST 2024, time=2024-04-25, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2165427, encodeId=86f3216542ea7, content=为什么回顾性研究也邮件让我发provide the Institutional Review Board or ethical review board’s approval/exemption letter，我明明文章中已经提到which waived the requirement for informed consent because of the retrospective nature of this study啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e43b5476402, createdName=ms4000001768031770, createdTime=Sat Oct 28 16:07:09 CST 2023, time=2023-10-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2212175, encodeId=035c22121e55f, content=审稿速度:1.0<br>偏重的研究方向：内分泌<br>经验分享：请问大家公共数据库是要自己上传还是等编辑通知啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87718511581, createdName=ms7000001498738258, createdTime=Fri Jun 28 21:31:36 CST 2024, time=2024-06-28, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=525028, encodeId=229f52502825, content=原来是Reject<span class="quote">Cactus2013 2016-07-19 发表::<br>研究方向：内分泌;; 06/26/2016 投稿 07/02/2016 Under Review 07/18/2016 Under Review 昨天又更新了一下under review 的日期，不知是几个意思？ </span>, beContent=Cactus2013 2016-07-19 发表:: 研究方向：内分泌;; 06/26/2016 投稿 07/02/2016 Under Review 07/18/2016 Under Review 昨天又更新了一下under review 的日期，不知是几个意思？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=368, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b63d81413, createdName=Cactus2018, createdTime=Thu Jul 21 08:27:00 CST 2016, time=2016-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944787, encodeId=ab53944e87d6, content=2020.09.22投稿，一审3个月，催稿问了下，说是前两个审稿人意见有分歧，所以邀请了第三个审稿人；返回大修2个月；2021.02.04再投，目前with editor了，希望能接收，祈祷, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=795, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLFHmdHZlP01VibUiaSUygPr1vfgUOicNUzicicuib25U9FM5WbtwPBfX6diaZbduz72Vjf0KFc8TINLKKvA/132, createdBy=d1062255989, createdName=延光星辰, createdTime=Tue Mar 02 14:31:35 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571551, encodeId=a9d65e155113, content=审稿速度:3.0<br>经验分享：于2019年2月26日投稿，一篇meta，然后5月18日直接被拒，三个月啊。编者的建议主要是我纳入的中文文献库（CNKI和万方），他们无法重复。所以纳入中文文献的meta慎投这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/0icicabQPFRfglHZr0mpDfC2oYjwL5n0xDc0wODUNEyWJuia9wXP3TnHwrZMktLMl7OQH7ZoUicGQHiclLb373GdibAg/132, createdBy=b44f2541766, createdName=lucifer11, createdTime=Mon May 27 16:57:00 CST 2019, time=2019-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182073, encodeId=9c2d21820e320, content=审稿速度:1.0<br>偏重的研究方向：代谢内分泌<br>经验分享：1.9号投的稿，已经过去7天了，一直在with editor的状态。想请教各位大佬何时才会under review呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d4b8504046, createdName=ms8000001820221539, createdTime=Tue Jan 16 21:41:20 CST 2024, time=2024-01-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2195585, encodeId=5f702195585d8, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：3月18日 投稿，到现在 一直是 Manuscript Submitted！什么情况，我看着大家的速度都挺快啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7b725453206, createdName=ms8000000183026287, createdTime=Wed Mar 27 06:41:54 CST 2024, time=2024-03-27, status=1, ipAttribution=山东省)]
    2016-07-21 Cactus2018

    原来是RejectCactus2013 2016-07-19 发表::
    研究方向：内分泌;; 06/26/2016 投稿 07/02/2016 Under Review 07/18/2016 Under Review 昨天又更新了一下under review 的日期，不知是几个意思？

    Cactus2013 2016-07-19 发表:: 研究方向：内分泌;; 06/26/2016 投稿 07/02/2016 Under Review 07/18/2016 Under Review 昨天又更新了一下under review 的日期，不知是几个意思？

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2210203, encodeId=3aa2221020358, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：心血管<br>经验分享：心血管方向，3月26日投稿，三天后技术审查要求提供英文伦理，修改后继续投稿，4月24日返修回来，两个审稿人，总共10条意见，总体很友好，算小修，要求6月22日之前返修回去，5月22日返修回去，经历了under review,6月9日正式接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59c75169226, createdName=146d2680m73(暂无昵称), createdTime=Sun Jun 16 20:32:46 CST 2024, time=2024-06-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2210204, encodeId=48be2210204ba, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：心血管<br>经验分享：心血管方向，3月26日投稿，三天后技术审查要求提供英文伦理，修改后继续投稿，4月24日返修回来，两个审稿人，总共10条意见，总体很友好，算小修，要求6月22日之前返修回去，5月22日返修回去，经历了under review,6月9日正式接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59c75169226, createdName=146d2680m73(暂无昵称), createdTime=Sun Jun 16 20:33:47 CST 2024, time=2024-06-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2200334, encodeId=be5122003344b, content=3-30投稿，4-5under review，4-24 with editor，希望有revise, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7bfb2469150, createdName=jolin_story_47656629, createdTime=Thu Apr 25 12:38:44 CST 2024, time=2024-04-25, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2165427, encodeId=86f3216542ea7, content=为什么回顾性研究也邮件让我发provide the Institutional Review Board or ethical review board’s approval/exemption letter，我明明文章中已经提到which waived the requirement for informed consent because of the retrospective nature of this study啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e43b5476402, createdName=ms4000001768031770, createdTime=Sat Oct 28 16:07:09 CST 2023, time=2023-10-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2212175, encodeId=035c22121e55f, content=审稿速度:1.0<br>偏重的研究方向：内分泌<br>经验分享：请问大家公共数据库是要自己上传还是等编辑通知啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87718511581, createdName=ms7000001498738258, createdTime=Fri Jun 28 21:31:36 CST 2024, time=2024-06-28, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=525028, encodeId=229f52502825, content=原来是Reject<span class="quote">Cactus2013 2016-07-19 发表::<br>研究方向：内分泌;; 06/26/2016 投稿 07/02/2016 Under Review 07/18/2016 Under Review 昨天又更新了一下under review 的日期，不知是几个意思？ </span>, beContent=Cactus2013 2016-07-19 发表:: 研究方向：内分泌;; 06/26/2016 投稿 07/02/2016 Under Review 07/18/2016 Under Review 昨天又更新了一下under review 的日期，不知是几个意思？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=368, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b63d81413, createdName=Cactus2018, createdTime=Thu Jul 21 08:27:00 CST 2016, time=2016-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944787, encodeId=ab53944e87d6, content=2020.09.22投稿，一审3个月，催稿问了下，说是前两个审稿人意见有分歧，所以邀请了第三个审稿人；返回大修2个月；2021.02.04再投，目前with editor了，希望能接收，祈祷, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=795, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLFHmdHZlP01VibUiaSUygPr1vfgUOicNUzicicuib25U9FM5WbtwPBfX6diaZbduz72Vjf0KFc8TINLKKvA/132, createdBy=d1062255989, createdName=延光星辰, createdTime=Tue Mar 02 14:31:35 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571551, encodeId=a9d65e155113, content=审稿速度:3.0<br>经验分享：于2019年2月26日投稿，一篇meta，然后5月18日直接被拒，三个月啊。编者的建议主要是我纳入的中文文献库（CNKI和万方），他们无法重复。所以纳入中文文献的meta慎投这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/0icicabQPFRfglHZr0mpDfC2oYjwL5n0xDc0wODUNEyWJuia9wXP3TnHwrZMktLMl7OQH7ZoUicGQHiclLb373GdibAg/132, createdBy=b44f2541766, createdName=lucifer11, createdTime=Mon May 27 16:57:00 CST 2019, time=2019-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182073, encodeId=9c2d21820e320, content=审稿速度:1.0<br>偏重的研究方向：代谢内分泌<br>经验分享：1.9号投的稿，已经过去7天了，一直在with editor的状态。想请教各位大佬何时才会under review呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d4b8504046, createdName=ms8000001820221539, createdTime=Tue Jan 16 21:41:20 CST 2024, time=2024-01-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2195585, encodeId=5f702195585d8, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：3月18日 投稿，到现在 一直是 Manuscript Submitted！什么情况，我看着大家的速度都挺快啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7b725453206, createdName=ms8000000183026287, createdTime=Wed Mar 27 06:41:54 CST 2024, time=2024-03-27, status=1, ipAttribution=山东省)]
    2021-03-02 延光星辰

    2020.09.22投稿，一审3个月，催稿问了下，说是前两个审稿人意见有分歧，所以邀请了第三个审稿人；返回大修2个月；2021.02.04再投，目前with editor了，希望能接收，祈祷

    7

    展开7条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2210203, encodeId=3aa2221020358, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：心血管<br>经验分享：心血管方向，3月26日投稿，三天后技术审查要求提供英文伦理，修改后继续投稿，4月24日返修回来，两个审稿人，总共10条意见，总体很友好，算小修，要求6月22日之前返修回去，5月22日返修回去，经历了under review,6月9日正式接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59c75169226, createdName=146d2680m73(暂无昵称), createdTime=Sun Jun 16 20:32:46 CST 2024, time=2024-06-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2210204, encodeId=48be2210204ba, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：心血管<br>经验分享：心血管方向，3月26日投稿，三天后技术审查要求提供英文伦理，修改后继续投稿，4月24日返修回来，两个审稿人，总共10条意见，总体很友好，算小修，要求6月22日之前返修回去，5月22日返修回去，经历了under review,6月9日正式接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59c75169226, createdName=146d2680m73(暂无昵称), createdTime=Sun Jun 16 20:33:47 CST 2024, time=2024-06-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2200334, encodeId=be5122003344b, content=3-30投稿，4-5under review，4-24 with editor，希望有revise, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7bfb2469150, createdName=jolin_story_47656629, createdTime=Thu Apr 25 12:38:44 CST 2024, time=2024-04-25, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2165427, encodeId=86f3216542ea7, content=为什么回顾性研究也邮件让我发provide the Institutional Review Board or ethical review board’s approval/exemption letter，我明明文章中已经提到which waived the requirement for informed consent because of the retrospective nature of this study啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e43b5476402, createdName=ms4000001768031770, createdTime=Sat Oct 28 16:07:09 CST 2023, time=2023-10-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2212175, encodeId=035c22121e55f, content=审稿速度:1.0<br>偏重的研究方向：内分泌<br>经验分享：请问大家公共数据库是要自己上传还是等编辑通知啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87718511581, createdName=ms7000001498738258, createdTime=Fri Jun 28 21:31:36 CST 2024, time=2024-06-28, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=525028, encodeId=229f52502825, content=原来是Reject<span class="quote">Cactus2013 2016-07-19 发表::<br>研究方向：内分泌;; 06/26/2016 投稿 07/02/2016 Under Review 07/18/2016 Under Review 昨天又更新了一下under review 的日期，不知是几个意思？ </span>, beContent=Cactus2013 2016-07-19 发表:: 研究方向：内分泌;; 06/26/2016 投稿 07/02/2016 Under Review 07/18/2016 Under Review 昨天又更新了一下under review 的日期，不知是几个意思？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=368, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b63d81413, createdName=Cactus2018, createdTime=Thu Jul 21 08:27:00 CST 2016, time=2016-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944787, encodeId=ab53944e87d6, content=2020.09.22投稿，一审3个月，催稿问了下，说是前两个审稿人意见有分歧，所以邀请了第三个审稿人；返回大修2个月；2021.02.04再投，目前with editor了，希望能接收，祈祷, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=795, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLFHmdHZlP01VibUiaSUygPr1vfgUOicNUzicicuib25U9FM5WbtwPBfX6diaZbduz72Vjf0KFc8TINLKKvA/132, createdBy=d1062255989, createdName=延光星辰, createdTime=Tue Mar 02 14:31:35 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571551, encodeId=a9d65e155113, content=审稿速度:3.0<br>经验分享：于2019年2月26日投稿，一篇meta，然后5月18日直接被拒，三个月啊。编者的建议主要是我纳入的中文文献库（CNKI和万方），他们无法重复。所以纳入中文文献的meta慎投这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/0icicabQPFRfglHZr0mpDfC2oYjwL5n0xDc0wODUNEyWJuia9wXP3TnHwrZMktLMl7OQH7ZoUicGQHiclLb373GdibAg/132, createdBy=b44f2541766, createdName=lucifer11, createdTime=Mon May 27 16:57:00 CST 2019, time=2019-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182073, encodeId=9c2d21820e320, content=审稿速度:1.0<br>偏重的研究方向：代谢内分泌<br>经验分享：1.9号投的稿，已经过去7天了，一直在with editor的状态。想请教各位大佬何时才会under review呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d4b8504046, createdName=ms8000001820221539, createdTime=Tue Jan 16 21:41:20 CST 2024, time=2024-01-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2195585, encodeId=5f702195585d8, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：3月18日 投稿，到现在 一直是 Manuscript Submitted！什么情况，我看着大家的速度都挺快啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7b725453206, createdName=ms8000000183026287, createdTime=Wed Mar 27 06:41:54 CST 2024, time=2024-03-27, status=1, ipAttribution=山东省)]
    2019-05-27 lucifer11

    审稿速度:3.0
    经验分享：于2019年2月26日投稿，一篇meta，然后5月18日直接被拒，三个月啊。编者的建议主要是我纳入的中文文献库（CNKI和万方），他们无法重复。所以纳入中文文献的meta慎投这个杂志。

    2

    展开2条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2210203, encodeId=3aa2221020358, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：心血管<br>经验分享：心血管方向，3月26日投稿，三天后技术审查要求提供英文伦理，修改后继续投稿，4月24日返修回来，两个审稿人，总共10条意见，总体很友好，算小修，要求6月22日之前返修回去，5月22日返修回去，经历了under review,6月9日正式接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59c75169226, createdName=146d2680m73(暂无昵称), createdTime=Sun Jun 16 20:32:46 CST 2024, time=2024-06-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2210204, encodeId=48be2210204ba, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：心血管<br>经验分享：心血管方向，3月26日投稿，三天后技术审查要求提供英文伦理，修改后继续投稿，4月24日返修回来，两个审稿人，总共10条意见，总体很友好，算小修，要求6月22日之前返修回去，5月22日返修回去，经历了under review,6月9日正式接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59c75169226, createdName=146d2680m73(暂无昵称), createdTime=Sun Jun 16 20:33:47 CST 2024, time=2024-06-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2200334, encodeId=be5122003344b, content=3-30投稿，4-5under review，4-24 with editor，希望有revise, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7bfb2469150, createdName=jolin_story_47656629, createdTime=Thu Apr 25 12:38:44 CST 2024, time=2024-04-25, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2165427, encodeId=86f3216542ea7, content=为什么回顾性研究也邮件让我发provide the Institutional Review Board or ethical review board’s approval/exemption letter，我明明文章中已经提到which waived the requirement for informed consent because of the retrospective nature of this study啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e43b5476402, createdName=ms4000001768031770, createdTime=Sat Oct 28 16:07:09 CST 2023, time=2023-10-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2212175, encodeId=035c22121e55f, content=审稿速度:1.0<br>偏重的研究方向：内分泌<br>经验分享：请问大家公共数据库是要自己上传还是等编辑通知啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87718511581, createdName=ms7000001498738258, createdTime=Fri Jun 28 21:31:36 CST 2024, time=2024-06-28, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=525028, encodeId=229f52502825, content=原来是Reject<span class="quote">Cactus2013 2016-07-19 发表::<br>研究方向：内分泌;; 06/26/2016 投稿 07/02/2016 Under Review 07/18/2016 Under Review 昨天又更新了一下under review 的日期，不知是几个意思？ </span>, beContent=Cactus2013 2016-07-19 发表:: 研究方向：内分泌;; 06/26/2016 投稿 07/02/2016 Under Review 07/18/2016 Under Review 昨天又更新了一下under review 的日期，不知是几个意思？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=368, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b63d81413, createdName=Cactus2018, createdTime=Thu Jul 21 08:27:00 CST 2016, time=2016-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944787, encodeId=ab53944e87d6, content=2020.09.22投稿，一审3个月，催稿问了下，说是前两个审稿人意见有分歧，所以邀请了第三个审稿人；返回大修2个月；2021.02.04再投，目前with editor了，希望能接收，祈祷, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=795, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLFHmdHZlP01VibUiaSUygPr1vfgUOicNUzicicuib25U9FM5WbtwPBfX6diaZbduz72Vjf0KFc8TINLKKvA/132, createdBy=d1062255989, createdName=延光星辰, createdTime=Tue Mar 02 14:31:35 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571551, encodeId=a9d65e155113, content=审稿速度:3.0<br>经验分享：于2019年2月26日投稿，一篇meta，然后5月18日直接被拒，三个月啊。编者的建议主要是我纳入的中文文献库（CNKI和万方），他们无法重复。所以纳入中文文献的meta慎投这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/0icicabQPFRfglHZr0mpDfC2oYjwL5n0xDc0wODUNEyWJuia9wXP3TnHwrZMktLMl7OQH7ZoUicGQHiclLb373GdibAg/132, createdBy=b44f2541766, createdName=lucifer11, createdTime=Mon May 27 16:57:00 CST 2019, time=2019-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182073, encodeId=9c2d21820e320, content=审稿速度:1.0<br>偏重的研究方向：代谢内分泌<br>经验分享：1.9号投的稿，已经过去7天了，一直在with editor的状态。想请教各位大佬何时才会under review呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d4b8504046, createdName=ms8000001820221539, createdTime=Tue Jan 16 21:41:20 CST 2024, time=2024-01-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2195585, encodeId=5f702195585d8, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：3月18日 投稿，到现在 一直是 Manuscript Submitted！什么情况，我看着大家的速度都挺快啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7b725453206, createdName=ms8000000183026287, createdTime=Wed Mar 27 06:41:54 CST 2024, time=2024-03-27, status=1, ipAttribution=山东省)]
    2024-01-16 ms8000001820221539 来自湖南省

    审稿速度:1.0
    偏重的研究方向：代谢内分泌
    经验分享：1.9号投的稿，已经过去7天了，一直在with editor的状态。想请教各位大佬何时才会under review呀

    4

    展开4条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2210203, encodeId=3aa2221020358, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：心血管<br>经验分享：心血管方向，3月26日投稿，三天后技术审查要求提供英文伦理，修改后继续投稿，4月24日返修回来，两个审稿人，总共10条意见，总体很友好，算小修，要求6月22日之前返修回去，5月22日返修回去，经历了under review,6月9日正式接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59c75169226, createdName=146d2680m73(暂无昵称), createdTime=Sun Jun 16 20:32:46 CST 2024, time=2024-06-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2210204, encodeId=48be2210204ba, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：心血管<br>经验分享：心血管方向，3月26日投稿，三天后技术审查要求提供英文伦理，修改后继续投稿，4月24日返修回来，两个审稿人，总共10条意见，总体很友好，算小修，要求6月22日之前返修回去，5月22日返修回去，经历了under review,6月9日正式接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59c75169226, createdName=146d2680m73(暂无昵称), createdTime=Sun Jun 16 20:33:47 CST 2024, time=2024-06-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2200334, encodeId=be5122003344b, content=3-30投稿，4-5under review，4-24 with editor，希望有revise, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7bfb2469150, createdName=jolin_story_47656629, createdTime=Thu Apr 25 12:38:44 CST 2024, time=2024-04-25, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2165427, encodeId=86f3216542ea7, content=为什么回顾性研究也邮件让我发provide the Institutional Review Board or ethical review board’s approval/exemption letter，我明明文章中已经提到which waived the requirement for informed consent because of the retrospective nature of this study啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e43b5476402, createdName=ms4000001768031770, createdTime=Sat Oct 28 16:07:09 CST 2023, time=2023-10-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2212175, encodeId=035c22121e55f, content=审稿速度:1.0<br>偏重的研究方向：内分泌<br>经验分享：请问大家公共数据库是要自己上传还是等编辑通知啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87718511581, createdName=ms7000001498738258, createdTime=Fri Jun 28 21:31:36 CST 2024, time=2024-06-28, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=525028, encodeId=229f52502825, content=原来是Reject<span class="quote">Cactus2013 2016-07-19 发表::<br>研究方向：内分泌;; 06/26/2016 投稿 07/02/2016 Under Review 07/18/2016 Under Review 昨天又更新了一下under review 的日期，不知是几个意思？ </span>, beContent=Cactus2013 2016-07-19 发表:: 研究方向：内分泌;; 06/26/2016 投稿 07/02/2016 Under Review 07/18/2016 Under Review 昨天又更新了一下under review 的日期，不知是几个意思？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=368, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b63d81413, createdName=Cactus2018, createdTime=Thu Jul 21 08:27:00 CST 2016, time=2016-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944787, encodeId=ab53944e87d6, content=2020.09.22投稿，一审3个月，催稿问了下，说是前两个审稿人意见有分歧，所以邀请了第三个审稿人；返回大修2个月；2021.02.04再投，目前with editor了，希望能接收，祈祷, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=795, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLFHmdHZlP01VibUiaSUygPr1vfgUOicNUzicicuib25U9FM5WbtwPBfX6diaZbduz72Vjf0KFc8TINLKKvA/132, createdBy=d1062255989, createdName=延光星辰, createdTime=Tue Mar 02 14:31:35 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571551, encodeId=a9d65e155113, content=审稿速度:3.0<br>经验分享：于2019年2月26日投稿，一篇meta，然后5月18日直接被拒，三个月啊。编者的建议主要是我纳入的中文文献库（CNKI和万方），他们无法重复。所以纳入中文文献的meta慎投这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/0icicabQPFRfglHZr0mpDfC2oYjwL5n0xDc0wODUNEyWJuia9wXP3TnHwrZMktLMl7OQH7ZoUicGQHiclLb373GdibAg/132, createdBy=b44f2541766, createdName=lucifer11, createdTime=Mon May 27 16:57:00 CST 2019, time=2019-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182073, encodeId=9c2d21820e320, content=审稿速度:1.0<br>偏重的研究方向：代谢内分泌<br>经验分享：1.9号投的稿，已经过去7天了，一直在with editor的状态。想请教各位大佬何时才会under review呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d4b8504046, createdName=ms8000001820221539, createdTime=Tue Jan 16 21:41:20 CST 2024, time=2024-01-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2195585, encodeId=5f702195585d8, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：3月18日 投稿，到现在 一直是 Manuscript Submitted！什么情况，我看着大家的速度都挺快啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7b725453206, createdName=ms8000000183026287, createdTime=Wed Mar 27 06:41:54 CST 2024, time=2024-03-27, status=1, ipAttribution=山东省)]
    2024-03-27 ms8000000183026287 来自山东省

    审稿速度:3.0 | 投稿命中率:25.0
    经验分享：3月18日 投稿，到现在 一直是 Manuscript Submitted！什么情况，我看着大家的速度都挺快啊

    3

    展开3条回复
共206条页码: 1/21页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map